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1. Introduction 
The calcium-binding protein calmodulln is thought 
to regulate awide range of cellular and enzymic func- 
tions [1,2]. The antipsychotic phenothiazine family 
of drugs inhibits the actions of calcium-calmodulin 
complexes [3], and this has led to the widespread use 
of these drugs as indicators of calmodulin involvement 
in specific biochemical nd cellular functions. Drugs 
with local anaesthetic a tivity also inhibit calmodulln 
function in isolated systems [4,5 ]. Among the enzymes 
regulated by calmodulln ismyosin light chain kinase, 
which controls the activity of cytoskeletal ctomyosin 
ATPase. This complex is thought o be involved in 
many processes related to cell motility, including cap 
formation on lymphocytes [6,7], and as part of a 
study of the latter process we have tested some of the 
reported calmodulln antagonists. To attribute any 
effects of the drugs to the inhibition of calmodulin, it
is necessary to show that they do not have other inde- 
pendent metabolic effects. In particular we have 
examined their effects on lymphocyte adenine nucle- 
otide levels, since we had shown that there is a quan- 
titative dependence of cap formation on the ATP 
level [8]. We have also tested the effects of the drugs 
on lymphocyte lactate output, since changes in ade- 
nine nucleotide l vels would be expected to affect 
the glycolytic flux. 
The results indicate that each of the drugs tested 
can reduce lymphocyte ATP levels, greatly reducing 
the phosphorylation potential, expressed aslog [ATP]/ 
[ADP]. This finding may explain many of the effects 
Abbreviations: FITC-RaMIg, fluorescein-conjugated rabbit 
anti-mouse IgG; Hepes, 4-(2 -hydroxyethyl)-I -piperazine- 
ethanesulfonic acid; LDH, lactate dehydrogenase; PBS, phos- 
phate-buffered saline 
of the drugs, independently of any inhibition of cal- 
modulin function, and therefore seriously limits their 
use as indicators of calmodulin function in intact cells. 
2. Materials and methods 
Spleen cells and thymocytes from 4-8-week old 
BALB/c mice and 6-month old Wistar rats were iso. 
lated as in [8] and were suspended at1-2 X 107 ceils/ 
ml in RPMI 1640 medium (Flow Labs.) buffered at 
pH 7.3 with 10 mM 4-(2-hydroxyethyl)-I-piperazine- 
ethanesulfonic a id (Hepes; Scare). Cell viabilities, as 
judged by the exclusion of sodium eosin, were initially 
>95%, and drug-induced cytolysis was assessed by 
release of lactate dehydrogenase (LDH) as described 
below. Aliquots of the cell suspension were mixed 
with freshly prepared solutions of the inhibitors in 
medium or DMSO as appropriate, and were then 
divided into samples for assay of ATP and ADP, lac- 
tate output, LDH release or cap formation. Control 
incubations contained equivalent additions of medium 
or DMSO, which were ~<1% (v/v). 
ATP was assayed using the luciferin-luciferase 
method as in [8], and ADP was estimated from the 
increase in ATP in the neutrallsed lymphocyte extracts 
after incubation for 30 rain at 37°C with 0.5 mM 
phosphoenolpyruvate and50 ~g pyruvate kinase/ml 
(Boehringer) [9]. For the determination f lactate 
output, cell samples were briefly centrifuged (3 s at 
14 000 X g), and the supernatants (250 pl) were 
added to assay cocktail (750 pJ) to give final conc. 
0.4 M glycine, 0.3 M hydrazine and 2 mM NAD + (pH 
9.2) [lO]; the increase in absorption at 340 nm after 
incubation for 30 min at 37°C with 20/~g lactate 
dehydrogenase/ml (Boehringer) was measured in a " 
Perkin-Elmer model 557 spectrophotometer, r lative 
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to samples of medium that had been similarly pro- 
cessed. LDH release was assessed by the rate of 
decrease in absorbanee at340 nm after the addition 
of supernatants to assay cocktail (final cone. 1 mM 
pyruvate, 0.1 mM NADH in medium) at 37°C, and 
the total cellular LDH activity was determined by the 
addition of the detergent NP40 (1%, v/v) to cell 
samples. Cap formation on mouse spleen cells was ini- 
tiated by the addition of 300/ag/ml of fluorescein- 
conjugated rabbit anti-mouse IgG (FITC-RaMIg; 
Miles Labs.). After 15 min at 37°C the cells were fixed 
by the addition of 2% formaldehyde in phosphate- 
buffered saline (PBS), and were then washed twice in 
ice-cold PBS before examination under ultra-violet 
illumination in a Leitz Diavert Microscope. Between 
100-200 stained cells were counted per sample, and 
capping was scored as the percentage of these cells 
with caps covering <50% of the cell. The results thus 
obtained are expressed as a percentage of capping on 
control samples. 
Trifluoperazine dihydrochloride and fluphenazine 
dihydrochloride were obtained from Smith Kline and 
French Labs. and E. R. Squibb and Sons, respectively, 
and all other inhibitors were the generous gift of Dr 
J. M. Young of the Department of Pharmacology, 
University of Cambridge. 
3. Results 
The effects of trifluoperazine, chlorpromazine, 
dibucaine and lignocaine on the ATP levels of rodent 
lymphoeytes are shown in riga (upper): there is a 
progressive r duction in ATP as the concentration f
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Fig.1. Effects of trifluoperazine, chlorpromazine, dibucaine and lignocaine on lymphocyte ATP levels and lactate output. Rat 
spleen ceils (*), mouse spleen cells (m) or mouse thymocytes (A) were incubated at 37"C with the indicated rug concentrations. 
Upper: ATP (closed symbols) or lyric LDH release (o) were assayed after 15 min as in section 2. ATP results are the mean and 
range of duplicates from 1-3  expt with each cell type; LDH results are the combined mean and range from these experiments. 
Middle: The range of drug concentrations reducing the ATP level to 70-80% of control is indicated '75% ATP', and the range of 
drug concentrations reported to give 50% inhibition of calmodulin-mediated enzymic processes i indicated '1C5o'. References: tri- 
fluoperazine [3,4,11,12]; chlorpromazine [3~5,11,13]; dibucaine [4,5];llgnocaine [5]. Lower: Lactate output from thymocytes 
was assayed after 60 min as in section 2. The results are the mean and range from 2 duplicate xpt. 
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each drug is increased. Also shown is the drug-induced 
release of LDH from the cells in the same xperiments; 
comparison ofthe effects of trifluoperazine with those 
of lignocaine shows that there is no consistent corre- 
lation between reduction of ATP and release of LDH. 
Although LDH release is frequently used as an assay 
for toxic effects of drugs added to cells, the reduction 
in ATP is a more sensitive measure of functional im- 
pairment. For example, lymphocytes can withstand 
several hours of ATP depletion by sodium azide and 
then recover (on removal of azide by washing) to give 
normal capping [6,8]. 
When the ATP level is reduced to 70-80% of con- 
trol, there is a marked ecrease in the phosphorylation 
potential, expressed as log [ATP]/[ADP]. Tne ratio 
of ATP to ADP in resting lymphocytes is 7-8, but 
when the ATP level falls to <75%, the ratio falls to 2, 
independent of the drug used (phenothiazines, local 
anaesthetics, or the mitochondrial inhibitor sodium 
azide (fig.2)). In general, any enzymic process that 
involves the hydrolysis of ATP will be sensitive to 
such changes in the phosphorylation potential, irre- 
spective of any calcium (or calmodulin) regulation of 
the process. Therefore, the ranges of drug concentra- 
tions that reduced the ATP level to 70-80% of con- 
trol were compared with the concentration ranges 
reported to give 50% inhibition of isolated calmodulin. 
regulated processes (fig. i ,  middle; ranges marked '75% 
ATP' and 'ICso', respectively). On the basis of the 
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Fig.2. Effects of phenothiazines and local anaesthetics on
log [ATP]/[ADP] as a function of ATP level. Mouse spleen 
ceils were incubated for 15 min at 37°C with: trifluoperazine 
(10-100 t~M, o); ehlorpromazine (10-100 ~M, B); fluphen- 
azine (10-100 t~M, A); dibucaine (150-500 I~M, o); or ligno- 
caine (2.5-10 mM, A); and were then assayed for ATP and 
ADP as in section 2. Also shown ( - - - )  is the profile obtained 
using sodium azide (0.075-1.5 mM). 
relationship between these 2 concentration ranges, 
the phenothiazines and local anaesthetics an be 
divided into 2 groups. Trifluoperazine and dibucaine 
have little or no effect on lymphocyte ATP levels 
when used at their reported ICso for calmodulin, but 
give a depletion of ATP at concentrations that are not 
very much higher. However, chlorpromazine and ligno- 
caine give significant depletion of ATP when they 
are used at their reported ICso for calmodulin, and 
have no effect on ATP levels only when used at con- 
centrations which would not (according to previous 
reports) interact significantly with calmodulin. This 
also applies (not shown) to fluphenazine, a phenothi. 
azine, and the O-adrenergic antagonist propranolol, 
which has local anaesthetic and anti-calmodulin activ- 
ities [4]. 
As in other aerobic ells, glycolytic flux in lym- 
phocytes i increased when, as a result of the impair. 
ment of mitochondrial function, the ATP level is 
lowered. Fig.1 0ower) shows that trifluoperazine, 
chlorpromazine, dibucaine and lignocaine ach stimu- 
lated lymphocyte lactate output, although the magni- 
tude of the effects varied widely and lytic concentra- 
tions of trifluoperazine (and of fluphenazine, not 
shown) caused asharp decrease in output. Chlorprom- 
azine, lignocaine and non-lytic trifluoperazine con- 
centrations increased the lactate output when they 
reduced the ATP level over the range where the phos- 
phorylation potential falls; a similar relationship was 
obtained using sodium azide (not shown). Dibucaine, 
however, gave an increase in lactate output over a 
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Fig.3. Effects of phenothiazines and local anaesthetics oncap 
formation as a function of ATP level. Mouse spleen ceils 
were incubated for 15 rain at 37°C as in fig.2, and were then 
assayed for ATP or capping of surface immunoglobulin asin 
section 2. Also shown ( - - - )  is the prof'fle obtained using 
sodium azide (0.075 - 1.5 raM). 
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range of concentrations that included those reported 
to interact with calmodulin, despite the lack of effect 
of these concentrations oncellular ATP levels. Local 
anaesthetics are known to affect he activity of mem- 
brane proteins [14], andsince one of the controlling 
factors in lymphocyte glyeolytie flux is glucose uptake 
[15], the various effects of the drugs on lactate out- 
put might reflect, for example, a combination of 
effects on the glucose-transport system and cellular 
energy levels. 
In fig.3 we show that there is no inhibition of cap 
formation by phenothiazines and local anaesthetics at 
concentrations that do not reduce the ATP level, so 
that the effects of the drugs on capping may be 
explained simply in terms of their effects on nucleotide 
levels [16]. The possible involvement of ealmodulin, 
through, e.g., myosin light chain kinase activation, 
cannot be assessed in these experiments, since several 
aspects of cytoskeletal function (e.g., monomer- 
polymer steady-states [17,18])may be controlled by 
nucleotide l vels. 
4. Discussion 
It is clear that under the conditions used here the 
phenothiazines and local anaesthetics annot be used 
to infer the involvement of calmodulin i  either nito- 
genie stimulation (as indicated by lactate output [15 ]), 
or cap formation. This conclusion may apply more 
generally to the use of these drugs as indicators of cal- 
modulin function in intact cells, since the effects 
demonstrated here on cellular energy metabolism 
would be expected to interfere with any system for 
which ATP is either a substrate or a regulator. It may 
therefore be invalid to ascribe effects of trifluoper- 
azine noted only at high concentrations to the inhibi- 
tion of calmodulin [19,20], and it may be premature 
to suggest that local anaesthetics might act on calcium- 
mediated systems through the antagonism of calmo- 
dulin, while other mechanisms apply to calcium-inde- 
pendent systems [4]. Similarly, it would not be valid 
to assume that any effects of these drugs result from 
the severance of calcium-dependent li kages between 
membrane proteins and the cytoskeleton [7,21,22]. 
This limitation has been noted for the effects of chlor- 
promazine and other drugs on macrophage functions 
[23], and has been stressed for the effects of local 
anaesthetics oncapping, where an ATP-capping profile 
similar to fig.3 was demonstrated [16]. The use of 
phenothiazines as probes for the involvement of cal- 
modulin in 0~-adrenergic responses has also been ques- 
tioned, since trifluoperazine and chlorpromazine act 
as a-adrenergic antagonists in hepatocytes at similar 
concentrations to those reported to interact with cal- 
modulin [24,25]. 
A comparison of our data with those of other 
workers reveals considerable variability in the concen- 
trations of trifluoperazine r ported to inhibit capping. 
Thus, in [26], little effect of 20/aM trifluoperazine 
was found, while significant inhibition by 10/aM tri- 
fluoperazine was reported in [27], and half-maximal 
inhibition by 3/aM trifluoperazine was found in [28]. 
Where suitable metabolic controls have been performed, 
there is again much variation in the reported effects. 
Our results (fig.l) are intermediate b tween those in 
[29] (increased release of LDH after only 2 min 
preincubation fneutrophils with 10/aM trifluoper- 
azine) and [28] (no depletion ofneutrophil ATP after 
20 min incubation with higher trifluoperazine con- 
centrations). At least some part of this variability 
may be due to different amounts of (phospholipid) 
material present in the system (as shown for the new, 
highly hydrophobic calmodulin i hibitor R24571 
[30]), and this emphasizes the need for the appropriate 
metabolic ontrols to be performed in each system. 
Recent studies have correlated the antagonism of
calmodulin by the local anaesthetics and chlorprom- 
azine with their octanol-water partition coefficients 
[5,31,32], which raises the possibility that they may 
cause general membrane perturbations [31 ]; the 
effect on lymphocyte ATP levels probably results 
from interference with mitochondrial membrane 
function (compare [33,34]), although at higher con- 
centrations cytolytic effects also contribute. The 
demonstration that the correlation between calmodulin 
antagonism and the octanol-water partition coeffi- 
cient extends to the specifically-designed calmodulin 
inhibitor W-7 [5], suggests hat the use of this drug 
(and others uch as R24571) may be subject o limi- 
tations imilar to those described here. 
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